Supplements

Duloxetine treatment improves sleep quality and reduces pro-inflammatory cytokine levels in patients with major depressive disorder

After 4 weeks of duloxetine treatment (40-60 mg/day), patients with MDD showed significant improvements in sleep parameters including increased total sleep time (TST) and sleep efficiency (SE), and decreased wake after sleep onset (WASO). Serum levels of IL-1β, IL-8, IL-12, and IFN-γ were significantly reduced. Baseline and post-treatment correlations suggest a link between sleep improvement and inflammatory changes.

Last updated: Jul 7, 2026•0 RCTs•📖 Read as article →

Evidence Score

Evidence Score32/100
Human RCT☆☆☆☆☆
Meta-analysis☆☆☆☆☆
Mechanism☆☆☆☆☆
Safety☆☆☆☆☆
Confidencelow

Study Evidence

Study 1. Association between changes in sleep quality and serum pro-inflammatory cytokine levels in patients with major depressive disorder following duloxetine treatment.

observational

Xu Y, Gao W, Shan F, Xia Q, Liang J · Annals of general psychiatry (2026)

Participants: N/A
Duration: 4 weeks
Intervention: Duloxetine at a daily dose of 40-60 mg for 4 consecutive weeks
Outcome: Objective sleep parameters (TST, SE, WASO, REM latency) measured by polysomnography; serum levels of IL-1β, IL-6, IL-8, IL-12, TNF-α, and IFN-γ
Effect Size: N/A (t-values reported: TST t=-6.614, SE t=-6.631, WASO t=6.331, IL-1β t=4.759, IL-8 t=6.327, IL-12 t=6.194, IFN-γ t=8.713; all P<0.001)
Population: 74 patients with major depressive disorder (DSM-5 criteria, baseline 24-item HDRS score ≥20, no prior antidepressant or anti-inflammatory drug use within 3 months)

Result:

PubMed: 42366392DOI: 10.1186/s12991-026-00689-8

Mechanism Graph

Duloxetine inhibits serotonin and norepinephrine reuptake
↓
Reduces peripheral pro-inflammatory cytokine levels (IL-1β, IL-8, IL-12, IFN-γ)
↓
Improves objective sleep parameters (TST, SE, WASO)
↓
Correlation between sleep improvement and cytokine reduction suggests a link between anti-inflammatory effects and sleep regulation

Limitations

  • ⚠Open-label design without placebo control group
  • ⚠Short treatment duration (4 weeks) limits generalizability to long-term effects
  • ⚠Small sample size (n=74) and lack of healthy control group

Products

Affiliate links coming soon. We only recommend products that match the doses and forms used in the cited research.

References

  1. 1.Xu Y, Gao W, Shan F, Xia Q, Liang J. "Association between changes in sleep quality and serum pro-inflammatory cytokine levels in patients with major depressive disorder following duloxetine treatment.." Annals of general psychiatry, 2026. PMID: 42366392 DOI: 10.1186/s12991-026-00689-8
Disclaimer: This content is for educational purposes only and is not medical advice. Evidence scores reflect the quality and quantity of available research, not clinical recommendations. Always consult a healthcare professional before starting any supplement or intervention.